CC chemokine receptor (CCR)4, a high affinity receptor for the CC chemokine
s thymus and activation-regulated chemokine (TARC) and macrophage-derived c
hemokine (MDC), is expressed in the thymus and spleen, and also by peripher
al blood T cells, macrophages, platelets, and basophils. Recent studies hav
e shown that CCR4 is the major chemokine receptor expressed by T helper typ
e 2 (Th2) polarized cells. To study the in vivo role of CCR4, we have gener
ated CCR4-deficient (CCR4(-/-)) mice by gene targeting. CCR4(-/-) mice deve
loped normally. Splenocytes and thymocytes isolated from the CCR4(-/-) mice
failed to respond to the CCR4 ligands TARC and MDC, as expected, but also
surprisingly did not undergo chemotaxis in vitro in response to macrophage
inflammatory protein (MIP)-1 alpha. The CCR4 deletion had no effect on Th2
differentiation in vitro or in a Th2-dependent model of allergic airway inf
lammation. However, CCR4(-/-) mice exhibited significantly decreased mortal
ity on administration of high or low dose bacterial lipopolysaccharide (LPS
) compared with CCR4(+/+) mice. After high dose LPS treatment, serum levels
of tumor necrosis factor alpha, interleukin 1 beta, and MIP-1 alpha were r
educed in CCR4(-/-) mice, and decreased expression of MDC and MIP-2 mRNA wa
s detected in peritoneal exudate cells. Analysis of peritoneal lavage cells
from CCR4(-/-) mice by flow cytometry also revealed a significant decrease
in the F4/80(+) cell population. This may reflect a defect in the ability
of the CCR4(-/-) macrophages to be retained in the peritoneal cavity. Taken
together, our data reveal an unexpected role for CCR4 in the inflammatory
response leading to LPS-induced lethality.